Early Diagnosis of Rheumatoid Arthritis Crucial

Author: Wiley-Blackwell
Published: 2010/11/23 - Updated: 2023/09/19
Publication Type: Study - Peer-Reviewed: Yes
Contents: Summary - Introduction - Main - Related

Synopsis: Positive outcomes in rheumatoid arthritis (RA) are closely linked to early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs). Early diagnosis of rheumatoid arthritis is crucial to positive outcomes for patients, delay in assessment by rheumatologist increases risk of joint destruction and decreases remission chances. The World Health Organization (WHO) estimates that RA affects up to 1% of the population worldwide and is associated with increased morbidity, mortality, and healthcare costs.

Introduction

Positive outcomes in rheumatoid arthritis (RA) are closely linked to early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs). A study by researchers in the Netherlands found that patients who are assessed by rheumatologists soon after RA symptoms appear are more likely to experience less joint destruction and improved chances of DMARD-free disease remission. Details of this novel study are published in the December issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.

Main Digest

The World Health Organization (WHO) estimates that RA affects up to 1% of the population worldwide and is associated with increased morbidity, mortality, and healthcare costs. This chronic, systemic disease is characterized by inflammation in the lining of the joints which can frequently lead to joint damage. Current medical evidence suggests that early initiation of an optimal RA treatment strategy within 12 weeks of symptom onset can prevent joint damage, improve long-term function, and increase the likelihood of achieving disease remission.

Dr. Michael van der Linden and colleagues from the Leiden University Medical Center examined 1674 early arthritis patients from the Leiden Early Arthritis Clinic cohort. Of those participants, 598 (36%) were RA patients who were diagnosed between 1993 and 2006. Researchers studied the associations among total delay to physician assessment, achievement of DMARD-free-remission, and the rate of joint damage over a six-year follow-up period. Total delay was calculated as the sum of "patient delay" (time from symptom onset until patient seeks and is assessed by a general practitioner (GP)) and "GP delay" (time lapse between seeing the GP and a referral to- and appointment with a rheumatologist).

Results showed the median patient, GP, and total delay in evaluation of early arthritis patients were 2.4, 8.0, and 13.7 weeks, respectively.

"Early treatment intervention dramatically improves clinical outcomes in patients with RA," said Dr. van der Linden. "Our study presents the first evidence that RA patients who have a delay longer than 12 weeks between first symptoms and visiting a rheumatologist have a higher rate of joint destruction and lower chance of achieving a sustained DMARD-free remission."

In 69% of RA patients, an examination by a rheumatologist took place 12 or more weeks after symptoms began, which researchers suggest contributed to a joint destruction rate that was 1.3 times higher than patients assessed prior to 12 weeks. A delay in treatment was also associated with greater risk (1.87 hazard ratio) of not achieving DMARD-free disease remission.

In a related editorial published in this month's issue, Dr. Paul Emery, Arthritis Research UK Professor of Rheumatology and Head of Musculoskeletal Diseases at Chapel Allerton Hospital in the United Kingdom and Dr. Vivian Bykerk from Brigham and Women's Hospital in Boston, Massachusetts point out that previous studies showed delays to care are frequent, but the study by van der Linden et al. was the first to actually document the negative impact of delayed RA treatment.

"This data provides further evidence that rheumatologists have the greatest impact on patients with RA when they intervene early in the disease course," commented Dr. Emery.

He further noted strategies that may help reduce delays in care such as pre-screening referrals, an introduction of a specialized rheumatology referral form for GPs to use that identify urgent referrals, or set-up of central triage clinics.

Dr. van der Linden concluded:

"Our results highlight the importance of reducing the delay in assessment by a rheumatologist and further studies could test whether accelerated treatment leads to improved disease outcomes in RA."

The ACR and European League Against Rheumatism (EULAR) have set up a task force to address the issue of improving RA patient outcomes through early intervention.

References

"Long-term Impact of Delay in Assessment of Early Arthritis Patients." Michael P.M. van der Linden, Saskia le Cessie, Karim Raza, Diane van der Woude, Rachel Knevel, Tom W.J. Huizinga, Annette H.M. van der Helm-van Mil. Arthritis & Rheumatism; Published Online: August 18, 2010; Print Issue Date: December 2010.

"Long-Term Impact of Delay to Rheumatology Care in Patients with Early Arthritis." Vivian Bykerk and Paul Emery. Arthritis & Rheumatism; Published Online: August 18, 2010; Print Issue Date: December 2010.

Arthritis & Rheumatism is an official journal of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), a division of the College, and covers all aspects of inflammatory disease. The American College of Rheumatology is the professional organization who share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers.

Attribution/Source(s):

This peer reviewed publication titled Early Diagnosis of Rheumatoid Arthritis Crucial was chosen for publishing by Disabled World's editors due to its relevance to the disability community. While the content may have been edited for style, clarity, or brevity, it was originally authored by Wiley-Blackwell and published 2010/11/23 (Edit Update: 2023/09/19). For further details or clarifications, you can contact Wiley-Blackwell directly at wiley.com Disabled World does not provide any warranties or endorsements related to this article.

Related Publications


Share This Information To:
𝕏.com Facebook Reddit

Page Information, Citing and Disclaimer

Disabled World is an independent disability community founded in 2004 to provide news and information to people with disabilities, seniors, their family and carers. You can connect with us on social media such as X.com and Facebook.

Cite This Page (APA): Wiley-Blackwell. (2010, November 23). Early Diagnosis of Rheumatoid Arthritis Crucial. Disabled World. Retrieved May 20, 2024 from www.disabled-world.com/health/autoimmunediseases/rheumatoid-arthritis/ra-diagnosis.php

Permalink: <a href="https://www.disabled-world.com/health/autoimmunediseases/rheumatoid-arthritis/ra-diagnosis.php">Early Diagnosis of Rheumatoid Arthritis Crucial</a>: Positive outcomes in rheumatoid arthritis (RA) are closely linked to early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs).

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.